To investigate whether the δV1 threshold could accurately stratify HER2-positive breast cancer patients with differing pCR rates across hormone receptor status and HER2 expression intensity, a bar chart was generated for comparison (Figure A1). This evidence concerns the gene ERBB2 and breast carcinoma.